Correlation between serum TNF alpha and IL6 levels and severity of group A streptococcal infections
- PMID: 7660074
- DOI: 10.3109/00365549509018991
Correlation between serum TNF alpha and IL6 levels and severity of group A streptococcal infections
Abstract
The multiorgan failure syndrome caused by group A streptococci (GAS) designated streptococcal toxic shock syndrome (STSS) is believed to be mediated by cytokines induced by superantigens. In order to study the relationship between superantigen production, cytokine levels in patient sera, and clinical GAS manifestation we examined acute-phase sera and strains from 25 patients with GAS bacteremia. The patients had various disease manifestations, including STSS (44%), erysipelas (28%), septicemia (24%), wound infections (16%), and pneumonia (12%). Serotype T1M1 dominated, representing 56% of the isolates, but also strains of other serotypes were identified. The strains were found to produce the streptococcal pyrogenic exotoxins (Spe) A, B, and F, as determined by immuno-blot analyses. There was no difference in amounts of toxin produced between strains isolated from patients with different manifestations of disease. Levels of TNF alpha, IL1 alpha, IL6, IL8, and IFN gamma in acute-phase sera were determined by use of ELISA and RIA assays. The analyses showed higher levels of IL6 in sera from patients with STSS than in sera from patients with bacteremia without shock. TNF alpha was elevated in sera from patients with STSS, as compared to sera from patients with uncomplicated pharyngotonsillitis. No increase in the levels of IL1 alpha, IL8, and IFN gamma could be found in the patient sera and there was no difference in the level of those cytokines between the various patient categories.
Similar articles
-
Invasive group A streptococcal infections: T1M1 isolates expressing pyrogenic exotoxins A and B in combination with selective lack of toxin-neutralizing antibodies are associated with increased risk of streptococcal toxic shock syndrome.J Infect Dis. 1999 Aug;180(2):410-8. doi: 10.1086/314872. J Infect Dis. 1999. PMID: 10395857
-
Streptococcal pyrogenic exotoxin A, streptolysin O, exoenzymes, serotype and biotype profiles of Streptococcus pyogenes isolates from patients with toxic shock syndrome and other severe infections.Zentralbl Bakteriol. 1997 Oct;286(3):421-33. Zentralbl Bakteriol. 1997. PMID: 9361388
-
[Cytokines and nitric oxide in streptococcal toxic shock syndrome].Med Clin (Barc). 1995 Apr 1;104(12):458-60. Med Clin (Barc). 1995. PMID: 7739283 Spanish.
-
[Clinical and fundamental studies of streptococcal toxic shock syndrome].Nihon Rinsho. 2001 Apr;59(4):808-18. Nihon Rinsho. 2001. PMID: 11305011 Review. Japanese.
-
Staphylococcal and streptococcal pyrogenic toxins involved in toxic shock syndrome and related illnesses.Crit Rev Microbiol. 1990;17(4):251-72. doi: 10.3109/10408419009105728. Crit Rev Microbiol. 1990. PMID: 2206394 Review.
Cited by
-
A new reassortment of influenza A (H7N9) virus causing human infection in Beijing, 2014.Sci Rep. 2016 May 27;6:26624. doi: 10.1038/srep26624. Sci Rep. 2016. PMID: 27230107 Free PMC article.
-
Dextromethorphan efficiently increases bactericidal activity, attenuates inflammatory responses, and prevents group a streptococcal sepsis.Antimicrob Agents Chemother. 2011 Mar;55(3):967-73. doi: 10.1128/AAC.00950-10. Epub 2011 Jan 3. Antimicrob Agents Chemother. 2011. PMID: 21199930 Free PMC article.
-
Emerging role of the interleukin-8 cleaving enzyme SpyCEP in clinical Streptococcus pyogenes infection.J Infect Dis. 2009 Aug 15;200(4):555-63. doi: 10.1086/603541. J Infect Dis. 2009. PMID: 19591574 Free PMC article.
-
Synergistic effects of streptolysin S and streptococcal pyrogenic exotoxin B on the mouse model of group A streptococcal infection.Med Microbiol Immunol. 2012 Aug;201(3):357-69. doi: 10.1007/s00430-012-0241-6. Epub 2012 May 18. Med Microbiol Immunol. 2012. PMID: 22610375
-
Lipopolysaccharide triggers invasive streptococcal disease in mice through a tumour necrosis factor-alpha-dependent mechanism.Immunology. 2002 Mar;105(3):344-9. doi: 10.1046/j.1365-2567.2002.01372.x. Immunology. 2002. PMID: 11918696 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical